The product generates a coloured warning, recommends a conversation with a doctor and considers the interaction complete. For the GP, the work is just beginning.
Picture an explicitly hypothetical consultation. A patient arrives with fatigue, disrupted sleep and a wearable graph they have been studying for a week. One section is red. The app has supplied a physiological explanation that sounds plausible, but the report does not explain the units, uncertainty or basis for its interpretation.
The patient has a legitimate concern. The clinician now has two jobs: assess that concern and discover what the product has actually told them. The second job should feature somewhere in the company's account of its value.
Start with the person holding the phone
A patient bringing data is trying to make sense of an experience. They may have spent money, time and emotional effort looking for an explanation. Dismissing the device with a raised eyebrow does little to establish a useful clinical conversation.
The starting point remains what has happened, what is troubling the patient and what they hope to resolve. The GMC's good medical practice guidance centres assessment on the patient's history, needs and priorities, with clinical judgement informing subsequent care.
A wearable may contribute a helpful timeline. It may give the patient language for a pattern they struggled to describe. Those are potential benefits worth taking seriously. They should be evaluated alongside the possibility that a confident interpretation has narrowed the conversation prematurely.
The patient's symptoms do not become less real because the device's explanation is uncertain. Equally, the explanation does not become established merely because the symptoms are real.
A data export can transfer unfinished work
Sending a PDF is technically easy. Making its contents interpretable in a consultation requires more thought. A graph without defined units, an alert without an explanation or a score without a reference population leaves the recipient to reconstruct the missing context.
That work includes identifying the device version, understanding the output, distinguishing actual observations from reconstructed information and deciding whether the result is relevant to the patient's question. The clinician may then need to explain all of that in language the patient can use.
An export function therefore does not, by itself, demonstrate clinical integration. It can simply move an unresolved interpretation from the app into a healthcare appointment.
The commercial temptation is obvious: referral to a professional sounds responsible and reassuring. It becomes a product-design problem when the professional receives neither the information nor the support needed to handle the question efficiently. The GP should not be the unpaid missing feature.
Put the interpretation essentials in one place
A useful clinician-facing report would explain its purpose before presenting its most striking graph. The following is a proposed design standard for consumer wearable reports, rather than a description of any particular company's current export.
It should show the output's definition and units, the observation period, the amount of usable data, the relevant uncertainty, the product version and the evidence supporting that interpretation. If the product flags a change, the report should explain the comparison that generated the flag.
For example, a change relative to the same person's recent baseline means something different from a result outside a population reference interval. A clinician should be able to identify that distinction without opening several technical documents.
The report should also make the intended contribution clear. Is it summarising observations, highlighting a pattern or proposing a clinical interpretation? Those purposes create different questions. A concise account of the evidence and intended use would save more time than another page of colourful traces.
Count the appointment time honestly
Consider an illustrative workload calculation. If interpreting an unfamiliar report adds eight minutes to each of ten consultations, it creates 80 minutes of additional work. Those numbers are hypothetical; they are not an estimate of the effect of Clair or any other wearable.
The point is that a small cost at the individual interaction can become material across a service. Some of that time may produce worthwhile benefit. Some might have been avoided through better product documentation or clearer communication before the appointment.
The same analysis should include work after the consultation: reviewing supporting material, answering follow-up questions, recording the discussion and deciding whether further clinical assessment is indicated. Measuring only the app interaction would miss these consequences.
A company claiming to improve care should want to know where its product adds useful attention and where it adds avoidable friction. The distinction helps it build a better service and gives clinicians a reason to welcome the information.
Evaluate what happens after the alert
The NICE evidence standards framework for digital health technologies links claimed benefits to supporting evidence and considers effects on healthcare resources. That offers a useful discipline for examining a product's place in a care pathway.
For a wearable that encourages clinical conversations, an evaluation could follow the alert through to its consequences. Did it help the patient describe a relevant problem? Did it improve the clinician's assessment? How much time did interpretation require? What happened to subsequent contacts, investigations and the patient's understanding?
The right outcome is not automatically fewer appointments or more appointments. A useful product could bring someone to appropriate care sooner. It could also generate repeat contact without resolving uncertainty. Counting referrals alone would treat those outcomes as equivalent.
The comparison should reflect the care the patient would otherwise receive. A symptom diary, a structured questionnaire or a clearer summary might provide some of the same benefit with less interpretation work. A wearable's additional contribution is worth establishing directly.
Make the conversation a shared task
NICE's shared decision-making guidance emphasises discussing information in the context of what matters to the individual. That is easier when the product has explained its output clearly before the consultation begins.
A company can help by giving users an understandable account of what the graph represents, what question it may inform and what information to bring to the appointment. It should provide a route for technical questions that does not default to the patient's GP.
Clinicians can develop their own approach through focused learning, including the iatroX Tutor and CPD resources. That learning supports clinical interpretation; it should not require mastering every consumer product's undocumented scoring system.
Useful health technology earns a place in the conversation by improving what participants can understand or decide. If the product's final instruction creates work for someone else, that work belongs in its evidence and business model. A successful handover needs more than a button labelled share.
Frequently asked questions
Should a GP disregard information from a consumer wearable?
No. The information may help describe timing, patterns or concerns. Its clinical weight depends on what the output represents and how well that interpretation is supported, alongside the patient's broader assessment.
Does every wearable alert require an investigation?
An alert alone does not determine the next step. The relevant decision follows assessment of the patient's circumstances, the meaning of the output and the clinical question that needs answering.
What should manufacturers measure beyond app engagement?
They should examine interpretation time, clarity of handover, effects on clinical decisions and subsequent contacts, and whether patients gain useful understanding. Those outcomes help distinguish a helpful contribution from work merely transferred to a healthcare team.